Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Sulfur (S VI) based moieties, especially, the sulfonyl or sulfonamide based analogues have
showed a variety of pharmacological properties, and its derivatives propose a high degree …
showed a variety of pharmacological properties, and its derivatives propose a high degree …
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
CB Mishra, M Tiwari, CT Supuran - Medicinal Research …, 2020 - Wiley Online Library
Abstract Carbonic anhydrases (CAs, EC 4.2. 1.1) are widely distributed metalloenzymes in
both prokaryotes and eukaryotes. They efficiently catalyze the reversible hydration of carbon …
both prokaryotes and eukaryotes. They efficiently catalyze the reversible hydration of carbon …
Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?
V Alterio, A Di Fiore, K D'Ambrosio, CT Supuran… - Chemical …, 2012 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are ubiquitous metallo-enzymes, present
throughout most living organisms and encoded by five evolutionarily unrelated gene …
throughout most living organisms and encoded by five evolutionarily unrelated gene …
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors
Abstract Carbonic anhydrase (CA, EC 4.2. 1.1) is an enzyme and a very omnipresent zinc
metalloenzyme which catalyzed the reversible hydration and dehydration of carbon dioxide …
metalloenzyme which catalyzed the reversible hydration and dehydration of carbon dioxide …
[HTML][HTML] Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
CT Supuran - Expert opinion on therapeutic patents, 2018 - Taylor & Francis
The metalloenzyme carbonic anhydrase (CA, EC 4.2. 1.1) is ubiquitously expressed in
organisms all over the phylogenetic tree, with seven genetically distinct families known to …
organisms all over the phylogenetic tree, with seven genetically distinct families known to …
Carbonic anhydrase inhibitors
CT Supuran, A Scozzafava… - Medicinal research …, 2003 - Wiley Online Library
At least 14 different carbonic anhydrase (CA, EC 4.2. 1.1) isoforms were isolated in higher
vertebrates, where these zinc enzymes play crucial physiological roles. Some of these …
vertebrates, where these zinc enzymes play crucial physiological roles. Some of these …
Anticancer and antiviral sulfonamides
A Scozzafava, T Owa, A Mastrolorenzo… - Current medicinal …, 2003 - ingentaconnect.com
The sulfonamides constitute an important class of drugs, with several types of
pharmacological agents possessing antibacterial, anti-carbonic anhydrase, diuretic …
pharmacological agents possessing antibacterial, anti-carbonic anhydrase, diuretic …
Antiglaucoma carbonic anhydrase inhibitors: a patent review
Introduction: Glaucoma is one of the major causes of blindness, affecting together with age-
related macular degeneration> 70 million people worldwide. One of the therapeutic options …
related macular degeneration> 70 million people worldwide. One of the therapeutic options …
Carbonic anhydrases as targets for medicinal chemistry
CT Supuran, A Scozzafava - Bioorganic & medicinal chemistry, 2007 - Elsevier
Carbonic anhydrases (CAs, EC 4.2. 1.1) are zinc enzymes acting as efficient catalysts for the
reversible hydration of carbon dioxide to bicarbonate. 16 different α-CA isoforms were …
reversible hydration of carbon dioxide to bicarbonate. 16 different α-CA isoforms were …
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013)
F Carta, CT Supuran - Expert opinion on therapeutic patents, 2013 - Taylor & Francis
Introduction: The benzothiadiazines and high ceiling diuretics (hydrochlorothiazide,
hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide, furosemide …
hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide, furosemide …